Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2003
09/11/2003US20030171564 Novel argS
09/11/2003US20030171562 Amino acid derivative antibiotics dorrigocin, and lactimidomycin, culturing Streptomyces amphibiosporus; computer readable medium with stored nucleotide sequences information, computers for data processing
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171555 Antitumor agents
09/11/2003US20030171554 Tumour necrosis factor peptide binding antibodies
09/11/2003US20030171553 Tumour necrosis factor binding ligands
09/11/2003US20030171552 A single-chain T-cell receptor covalently linked to single-chain antibody; anticarcinogenic agents for treating cancer
09/11/2003US20030171551 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
09/11/2003US20030171550 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030171548 Immunoreactive proteins where the percentage of immuno-reactive molecules as determined in a modified Lindmo-test is >81%; fermentation of culture of fluidized reactor; diagnosis of inflammatory and bone marrow displacing process
09/11/2003US20030171547 Adipocyte-specific protein homologs
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171435 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
09/11/2003US20030171334 Treatment of prostate cancer
09/11/2003US20030171328 Non-invasive method for detecting target-RNA
09/11/2003US20030171326 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
09/11/2003US20030171323 Specifically for granuloma occurring after ligation of a deferent duct, comprising an antagonist against the scavenger receptor of macrophage, such as antibody, as an active ingredient.
09/11/2003US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the
09/11/2003US20030171273 DNA of SEQ ID NO:1 is provided that encodes the transcription factor BP1, which is believed to be a repressor of the beta -globin gene. A host cell that is transformed with a vector that contains the DNA may be used to produce BP1.
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030170917 4-Hydroxyalkylphenethamines, used as an intermediate, hapten, or immunogen in the production of antibodies specific for ecstasy drugs; binding the antibody to the analyte and detecting the adduct formed; immunoassay
09/11/2003US20030170864 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170849 Tyrosylprotein sulfotransferases
09/11/2003US20030170843 Carbohydrate crosslinked glycoprotein crystals
09/11/2003US20030170840 Genomic mammary amyloid a sequence
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170838 Novel polynucleotides and polypeptides encoded thereby
09/11/2003US20030170823 Polynucleotide encoding a polypeptide; induces proliferation or cytotoxicity in cells; use in increasing platelets and in detection of cancer, inflammation and genetic abnormalities
09/11/2003US20030170820 Mutation, synthesis and selection of a protein by incubating RNA with ribonucleoside triphosphate and polymerase; linked via ribosomes; translation
09/11/2003US20030170817 Molecule having an antigen binding region specific for an epitope recognized by the antibody produced by the hybridoma; prophylaxis and treatment of apoptosis related conditions
09/11/2003US20030170812 Interleukin-1beta converting enzyme like cysteine protease
09/11/2003US20030170808 Polypeptide encoded by polynucleotide of given sequence; use in diagnosis and treatment of various diseases
09/11/2003US20030170792 MAGE-3 peptides presented by HLA class ll molecules
09/11/2003US20030170790 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170789 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170788 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170786 Vascular endothelial growth factor 2
09/11/2003US20030170785 CDNA encoding the human alpha2 delta4 calcium channel subunit
09/11/2003US20030170782 Proteins
09/11/2003US20030170777 An isolated nucleic acid molecule that encodes the amino acid sequence, cell culturing, binding to antibody, non-human transgenic animal, antithrombotic drugs, treating cardiovascular diseases, genetic engineering
09/11/2003US20030170776 Antiinflammatory agents; kidney diseases; anticancer agents
09/11/2003US20030170763 Protein antiallergens
09/11/2003US20030170758 Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies
09/11/2003US20030170757 Diagnosis of cancer tissue; monoclonal antibodies
09/11/2003US20030170754 Anticancer agents; diagnosis of prostate cancer
09/11/2003US20030170753 Artificial antibody polypeptides
09/11/2003US20030170741 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors
09/11/2003US20030170727 Drug screening; cental nervous system disorders
09/11/2003US20030170721 Bonding to antibodies; genetic engineering
09/11/2003US20030170719 Antiinflammatory agents; autoimmune disease; anticancer agents
09/11/2003US20030170718 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170708 Screening for mutants; primer amplification
09/11/2003US20030170688 Determination binding protein; measuring antiproliferative agents; genetic engineering
09/11/2003US20030170679 Hybrid growth hormone
09/11/2003US20030170663 Nucleotide sequence of the Mycoplasma genitalium genome, fragments thereof, and uses thereof
09/11/2003US20030170647 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
09/11/2003US20030170646 Isolated bovine VDJ gene cassette comprising the nucleic acid sequence to develop chimeric immunoglobulin, for development of oral vaccines, vaccine vector, targeting specific tissues or organs
09/11/2003US20030170634 Polynucleotide encoding amylase; hydrolysis of starch
09/11/2003US20030170628 Forsenic analysis; medical diagnosis; chromosome markers
09/11/2003US20030170622 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
09/11/2003US20030170620 Gene controlling androgen
09/11/2003US20030170616 Diagnosis using antibodies; genetic engineering
09/11/2003US20030170615 Analyzing using monoclonal antibodies
09/11/2003US20030170269 Vaccine for mystery swine disease and method for diagnosis thereof
09/11/2003US20030170260 Binds antibodies specific for Rhodococcus equi and the VapA protein.
09/11/2003US20030170259 Chlamydia antigens and corresponding dna fragments and uses thereof
09/11/2003US20030170257 Protecting animals against the bite of blood-sucking ectoparasites and against the transmission of viruses, bacteria and other pathogens by such ectoparasites.
09/11/2003US20030170253 Useful in stimulating angiogenesis as well as in diagnostic applications.
09/11/2003US20030170252 Also a hybridoma cell capable of producing the antibody; anticancer agents
09/11/2003US20030170248 Constant region contains a human immunoglobulin and variable region contains a non-human immunoglobulin variable region; especially treating an infection caused by Enterohemorrhagic Escherichia coli
09/11/2003US20030170247 Methods for detection and treatment of neural cancers
09/11/2003US20030170246 Fusion protein, comprising a first lipophilin-like polypeptide linked by a peptide bond to a second lipophilin-like polypeptide; polynucleotides encoding the protein; antibodies; especially for breast, ovarian or prostate cancer.
09/11/2003US20030170245 Activation of matriptase and diagnostic and therapeutic methods based thereon
09/11/2003US20030170244 CD95 antigen induced apoptosis to treat bone marrow failure and to improve cancer therapies.
09/11/2003US20030170243 Use of human plasma hyaluronidase in cancer treatment
09/11/2003US20030170242 Novel isoforms of vascular endothelial cell growth inhibitor
09/11/2003US20030170241 Treatment of non-viral or non-autoimmune induced heart disorders such as ischaemic heart disease or chronic non-ischaemic cardiomyopathy by intravenous administration of immunoglobulin
09/11/2003US20030170239 Or for therapy for autoimmune diseases; administering compounds such as monoclonal antibodies, that bind specifically to CD40 and the CD4 receptor.
09/11/2003US20030170238 Increasing the cytokine production of T-cells; preferably the cells are allowed to rest after harvest and then are re-activated just prior to infusion.
09/11/2003US20030170237 G-CSF receptor agonist antibodies and screening method therefor
09/11/2003US20030170236 Identification and use of high efficacy vaccine antigens which modulate antigen presenting cells
09/11/2003US20030170235 Treatment with anti-ErbB2 antibodies
09/11/2003US20030170234 Combination of the antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin; treating cancer
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170232 Downmodulating an autoimmune response by administering an antigen binding portion of an anti-CD28 antibody that blocks signaling via CD28
09/11/2003US20030170231 Remedies and preventives for antiphospholipid antibody syndrome
09/11/2003US20030170230 Use of the AHEC region permits the assembly of antibody fragments into defined multimeric complexes
09/11/2003US20030170229 Epitopes or mimotopes derived from the C epsilon 3 or C epsilon 4 domains of IgE; prevention or amelioration of allergic disease.
09/11/2003US20030170228 Compositions and methods for the treatment of tumor
09/11/2003US20030170204 To enhance in vivo tumour regression activity of the TNF
09/11/2003US20030170203 Death domain containing receptors
09/11/2003US20030170175 Cytotoxic therapy
09/10/2003EP1342779A1 Means and methods for manipulating hypersensitivity-like responses
09/10/2003EP1342727A1 Antibody against norwalk virus and method of detecting virus by using the antibody
09/10/2003EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
09/10/2003EP1341926A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
09/10/2003EP1341921A2 Hydrolases
09/10/2003EP1341918A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/10/2003EP1341902A2 Chronic lymphocytic leukemia cell line and its use for producing an antibody
1 ... 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 ... 1494